
Benign prostate hyperplasia and normal prostate
p63 Protein (Autostainer Link 48)

Antibodies to p63 protein may be useful as an aid in the differentiation between benign prostate lesions and prostate adenocarcinoma, between breast carcinoma in situ and breast carcinoma, between squamous cell carcinoma and adenocarcinoma of the lung and furthermore to differentiate uterine cervical squamous carcinoma from cervical adenocarcinoma.
Clone DAK-p63 is raised against a synthetic peptide derived from the core DNA-binding domain of human p63 protein thus reacting with TAp63 and ΔNp63 isoforms of p63.